[2022.11] Absology draws attention from in vitro diagnostic device 'ABSOL' MEDICA > news

본문 바로가기
ABSOL VET Contact Us Login
Language
  • · Korean
  • · English

[2022.11] Absology draws attention from in vitro diagnostic device 'AB…

본문

17d0386fd624d8128382ea4c8abd66ec_1680592478_8193.png
 

[Summery] It is reported that Absolology Co., Ltd. (CEO Jo Han Sang) has won export contracts with Thailand and Italy for its in vitro immunodiagnostic device 'ABSOL' platform at MEDICA, the world's largest medical device exhibition held in Düsseldorf, Germany from November 11 ~ 14, attracting hot attention from overseas buyers.



http://www.bosa.co.kr/news/articleView.html?idxno=2185034 

Excerpt from Medical newspaper